ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Diagnosis-Treatment Cidac contract Gets Recompetition Okay

December 16, 1983

Pittsburgh, Norris Win Bristol-Myers Unrestricted Grants

April 19, 1991

New Breast Cancer Trials to Include Pre Vs. Post Operative Chemotherapy, CSF Pilot Studies

August 5, 1988

Poll Finds Strong Support For Research; Yarbro Leads International Cancer Nurses.

October 6, 2000

In Brief: NCAB Appointments: Boutwell Stay On; Brown, Elion, Strong, Korn Named; One Vacancy Remains

May 18, 1984